Netrin-1
Showing 9976 - 10000 of >10,000
COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)
Rectal Cancer Stage, Oesophageal Cancer Trial in Vienna (CRT, SCPRT, CROSS Protocol)
Not yet recruiting
- Rectal Cancer Stage
- Oesophageal Cancer
- CRT
- +3 more
-
Vienna, AustriaMedical University of Vienna
Mar 26, 2022
Autoimmune Inner Ear Disease Trial in New Hyde Park (Anakinra 100Mg/0.67Ml Inj Syringe (Period 1), Placebo injection (Period 1),
Recruiting
- Autoimmune Inner Ear Disease
- Anakinra 100Mg/0.67Ml Inj Syringe (Period 1)
- +3 more
-
New Hyde Park, New YorkNorthwell Health, Hearing& Speech Center
Oct 18, 2022
Advanced Solid Tumor Trial in Guangzhou (BAT1006)
Recruiting
- Advanced Solid Tumor
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jun 8, 2022
Acute Nasopharyngitis Trial in Vienna (2-Deoxyglucose, Placebo)
Recruiting
- Acute Nasopharyngitis
- 2-Deoxyglucose
- Placebo
-
Vienna, AustriaMedical University of Vienna
Mar 29, 2022
Familial Alzheimer (FAD), PSEN1 Mutation Trial in Japan (Bromocriptine, Placebos)
Completed
- Familial Alzheimer Disease (FAD)
- PSEN1 Mutation
- Bromocriptine
- Placebos
-
Nagoya, Aichi, Japan
- +7 more
Mar 29, 2022
Trauma Follow-Up Prediction (Project 2: Aim 1)
Not yet recruiting
- Trauma
- +2 more
- Standard mHealth screening (triage) tool
- (no location specified)
Jun 17, 2022
Refractory Chronic Cough Trial in Phoenix, Leesburg, Winter Park (3 mg NOC-100 (via nebulizer), 1 mg NOC-110 (via DPI) [1x 1 mg
Completed
- Refractory Chronic Cough
- 3 mg NOC-100 (via nebulizer)
- +5 more
-
Phoenix, Arizona
- +2 more
Nov 16, 2022
The Nanowear Wearable System SimpleSense Validation Trial for
Not yet recruiting
- Right Heart Catheterization
- SimpleSense
- (no location specified)
Nov 17, 2022
Hiv, Aids Trial in Kigali (Early spaced-out appointments)
Completed
- Hiv
- Aids
- Early spaced-out appointments
-
Kigali, RwandaRwanda Military Hospital
Aug 22, 2022
Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Duarte, Hackensack, Houston (SIRPant-M, External-beam
Not yet recruiting
- Refractory Non-Hodgkin Lymphoma
- Relapsed Non-Hodgkin Lymphoma
- SIRPant-M
- External-beam radiotherapy (XRT)
-
Duarte, California
- +2 more
Jul 21, 2023
Metabolic Syndrome X Trial in Madison (drug, device, other)
Completed
- Metabolic Syndrome X
- NOS Inhibition
- +6 more
-
Madison, WisconsinUniversity of Wisconsin, Madison
Oct 14, 2021
Carcinoma, Squamous Cell, Non-small-cell Lung Trial in Worldwide (Pembrolizumab, Carboplatin, Paclitaxel)
Active, not recruiting
- Carcinoma, Squamous Cell, Non-small-cell Lung
- Pembrolizumab
- +5 more
-
Birmingham, Alabama
- +177 more
Aug 22, 2022
CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
Recruiting
- Myocarditis
- +5 more
-
Paris, FranceAP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Aug 19, 2022
MDD, Post Traumatic Stress Disorder Trial in Newark, Cleveland, Seattle (Positive Processes and Transition to Health (PATH))
Recruiting
- Major Depressive Disorder
- Post Traumatic Stress Disorder
- Positive Processes and Transition to Health (PATH)
-
Newark, Delaware
- +2 more
Apr 28, 2022
1. Asthma Trial in Lincoln (SM17, Placebo)
Not yet recruiting
- 1. Asthma
- SM17
- Placebo
-
Lincoln, NebraskaCelerion Lincoln
Apr 18, 2022
Acute Ischemic Stroke, Arterial Thrombosis, Posterior Circulation Brain Infarction Trial in Beijing (intra-arterial alteplase)
Not yet recruiting
- Acute Ischemic Stroke
- +2 more
- intra-arterial alteplase
-
Beijing, ChinaXuanwu Hospital, Capital Medical University.
Jun 8, 2023
Opioid Use Disorder, Opioid Use Disorder, Severe, Opioid Dependence With Current Use (Disorder) Trial (Text Message Check-ins,
Not yet recruiting
- Opioid Use Disorder
- +4 more
- Text Message Check-ins
- Contingency Management
- (no location specified)
Jun 1, 2023
Amputation Stump Trial in Cambridge (Prosthetic socket for transtibial amputee)
Completed
- Amputation Stump
- Prosthetic socket for transtibial amputee
-
Cambridge, Massachusetts
- +1 more
Sep 28, 2022
Substance Use, Child Abuse, Child Neglect Trial (Motivational Enhancement, HERO Dads Fatherhood Program, Contingency Management)
Not yet recruiting
- Substance Use
- +4 more
- Motivational Enhancement
- +3 more
- (no location specified)
Sep 29, 2022
NSCLC Trial in Worldwide (Capmatinib, Amivantamab)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
-
Orange, California
- +40 more
Aug 3, 2022
Advanced Solid Tumor Trial in China (PD-1 mAb injection, TJ004309 Injection)
Recruiting
- Advanced Solid Tumor
- PD-1 monoclonal antibody injection
- TJ004309 Injection
-
Hefei, Anhui, China
- +25 more
Aug 2, 2022
Functional Near-Infrared Spectroscopy Combined With Diffuse
Recruiting
- Juvenile Neuronal Ceroid Lipofuscinosis
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 30, 2023